Delivery Order SPE2DB20D9331-SPE2DB25FL1X1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, operates under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $61,902.91 for MACI 3cm x 5cm implant sheets. The contract, issued on June 26, 2025, with an ultimate completion date of July 18, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The contract is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA's SPE2DB...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, and represents no set-aside designation. The award falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. The contract represents a discrete order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The contract is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and was awarded on August 7, 2025. This award utilizes no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market...
- The Defense Logistics Agency awarded a $61,902.91 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 26, 2025, for MACI 3cm x 5cm implant sheets, with an ultimate completion date of September 17, 2025. This delivery order was issued without a set-aside designation and represents a discrete procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The Park Ridge, Illinois-based woman-owned...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc. for MACI 3cm x 5cm implant sheets. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. The delivery order was issued on July 18, 2025, with an ultimate completion date of August 8, 2025, and no set-aside designation was used in this procurement...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of 4564165994 MACI 3CM X 5CM implant sheets with a potential value of $57,317.20. The contract has a completion date of March 12, 2024 and was awarded on February 20, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc. for MACI 3cm x 5cm implant sheets. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. The contract carries no set-aside designation and has an ultimate completion date of September 24, 2025. This delivery order is issued under DMS...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1X1Delivery Order
The Defense Logistics Agency awarded a $61,538.77 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for MACI 3cm x 5cm implant sheets. The contract, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical consumables supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent contract awards from the Defense Logistics Agency. The company's core business involves distributing branded and generic prescription drugs, biologics, and medical consumables directly to Department of Defense healthcare facilities. The MACI implant sheets represent a specialized pharmaceutical product within the company's broader portfolio of medical supplies, which includes oncology treatments, vaccines, contraceptive devices, and other injectable and specialty medications supporting military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.5k | 9/4/25 |